申请人:QILU REGOR THERAPEUTICS INC
公开号:WO2022155941A1
公开(公告)日:2022-07-28
The invention provides a compound represented by structural formula (I), or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating a disease or disorder associated with CDK2.
该发明提供了一种化合物,其结构式表示为(I),或其药学上可接受的盐,或其立体异构体,用于治疗与CDK2相关的疾病或障碍。